AfriMab-1

HER2‑positive breast cancer

PreclinicalActive

Key Facts

Indication

HER2‑positive breast cancer

Phase

Preclinical

Status

Active

Company

South African biotech delivering affordable vaccines and biosimilars using proprietary biologics platforms.

Drug	Company	Phase	Status
Herceptin (Trastuzumab) Biosimilar	NeuClone	Phase 1	Active
Perjeta (Pertuzumab) Biosimilar	NeuClone	Process Scale‑up	Active
MagSense™ HER2 Imaging Agent	Imagion Biosystems	Phase 2	Active
P-003	Panacea Biotec	Phase 3	Active
Trastuzumab Biosimilar	Hetero	Phase 3	Active
Legrand‑Herceptin Biosimilar	Laboratorios Legrand	Commercial	Active
Biosimilar Trastuzumab	Biosidus	Commercial	Active
Trazher	Innogene Kalbiotech	Commercial	Active
MINC‑trastuzumab	Suntec Medical	Preclinical	Active